Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research

News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971

AskBio Knocks Down Enough Hurdles To Raise $235m For Its Gene Therapy Platform

Thu, 04/11/2019 - 9:47pm

While some companies rushed into gene therapy and exited after a single setback, Asklepios BioPharmaceutical quietly advanced its programs, identifying...

      Related Stories 

How Abbott Is Making Incremental Innovation Count For Patients

Thu, 04/11/2019 - 1:22am

Abbott’s innovation and development center in Mumbai has made significant progress in shaping incremental but impactful innovations for India and...

      Related Stories 

South Korea's ADEL Innovates With Anti-Tau Antibody For Alzheimer’s Disease

Wed, 04/10/2019 - 5:44pm

Emerging Company Profile: ADEL Inc. CEO Seung-Yong Yoon tells Scrip how its anti-tau antibody brings something different to the table...

      Related Stories 

Asia Deal Watch: Antibody-Drug Conjugates Reign With Alliances Involving Celltrion, Miracogen & WuXi Biologics

Wed, 04/10/2019 - 12:50pm

Celltrion and iProgen will co-develop ADC candidates, Miracogen and Synaffix sign a technology license after a successful research collaboration, and...

      Related Stories 

Insulin Assistance Programs: Big Help Or Just A Band-Aid?

Wed, 04/10/2019 - 12:37pm

Drug makers and other stakeholders have been rolling out insulin savings programs as the high cost of insulins come under...

      Related Stories 

ReNeuron's Cell Therapies Attract Fosun Pharma, A Leading Regenerative Medicines Developer

Wed, 04/10/2019 - 8:20am

The UK cell therapy biotech ReNeuron has attracted the healthcare group, Fosun Pharma, which is building up a leading position...

      Related Stories 

VIDEO: BIO-Europe Spring 2019: Apeiron CEO On Pipeline Progress And Partnering

Wed, 04/10/2019 - 2:23am

Peter Llewellyn-Davies, CEO and chief financial officer of Apeiron Biologics, talks to Lucie Ellis, executive editor of In Vivo, on...

      Related Stories 

Positive Phase III Data Set Stage For Japan Imeglimin Filing

Tue, 04/09/2019 - 9:31pm

Partners Poxel and Sumitomo Dainippon confirm Japan filing plans for novel glimin antidiabetic following positive top-line Phase III results, and...

      Related Stories 

Debt-Laden Panacea's Shares Soar As $144m Rescue Agreed

Tue, 04/09/2019 - 5:56pm

A distressed asset fund run by Bain Capital Credit and Piramal Enterprises agrees a $144m bailout for financially ailing Indian...

      Related Stories 

PBMs Were On Capitol Hill, But Pharma Still Took Some Heat

Tue, 04/09/2019 - 5:35pm

Drug makers remained front and center during the Senate Finance Committee's third hearing on drug pricing, even though leaders from...

      Related Stories